London, United Kingdom · Founded 2012 · Privately Held (backing)
Operator of a biopharmaceutical company intended for developing bacterial immunotherapies for cancer. Prokarium is based in London, United Kingdom and was founded in 2012. Its last reported valuation was $109 million in Feb 2023. It has raised $88.8 million.
Last reported valuation
$109.4M
Oct 2026
Priced at
—
Total raised
$88.8M
Last round
—
Cap table — not yet on record
Prokarium's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Prokarium with a free account
·The complete investor list: 12 names
·Watch Prokarium: the Monday email on marks, rounds and moves
